...ultimately closing the loop between heterogeneity, immunomodulatory mechanisms, bioassay platforms and FDA approvals and the subsequent paradigm shift in standard inflammatory treatments may be accelerated with solid metabolic activity change profiles differentiating trial cohorts.
...sorry, I had the illusion I knew what I was talking about. Post deleted due to hubris. Dr. Trench has taken his shovel and gone back to the backyard.
...ultimately closing the loop between heterogeneity,...
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.055(3.77%) |
Mkt cap ! $1.729B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.54 | $1.45 | $6.072M | 4.049M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5951 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 133644 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |